Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease

This publication has 61 references indexed in Scilit:

• [¹¹C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length
  Annals of Neurology, 1998
• Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum
  Journal of Neurochemistry, 1997
• Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
  Science, 1997
• Striatal D₁ and D₂ receptor binding in patients with Huntington's disease and other choreas A PET study
  Brain, 1995
• Effects of striatal excitotoxicity on Huntingtin-like immunoreactivity
  NeuroReport, 1995
• Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus
  Developmental Brain Research, 1995
• Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: Iodobenzamide and iodoethylspiperone
  Life Sciences, 1993
• Striatal quinolinic acid lesions increase [3H]WIN 35,428 binding to the dopamine transporter
  Neurochemistry International, 1992
• Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum
  Experimental Neurology, 1991
• Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease
  New England Journal of Medicine, 1987